Recurrence of Punctate Inner Choroidopathy with an Intravitreal Dexamethasone Implantopen access
- Authors
- Shin, Min Ho; Kang, Hyun Ji; Chung, In Young
- Issue Date
- Nov-2017
- Publisher
- KOREAN OPHTHALMOLOGICAL SOC
- Keywords
- Intravitreal bevacizumab; Intravitreal dexamethasone implant; Punctate inner choroidopathy; Systemic steroid
- Citation
- JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, v.58, no.11, pp 1282 - 1288
- Pages
- 7
- Indexed
- KCI
- Journal Title
- JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY
- Volume
- 58
- Number
- 11
- Start Page
- 1282
- End Page
- 1288
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/13392
- DOI
- 10.3341/jkos.2017.58.11.1282
- ISSN
- 0378-6471
2092-9374
- Abstract
- Purpose: To report a case of punctate inner choroidopathy (PIC) treated with an intravitreal dexamethasone implant due to side effects of systemic steroid treatment. Case Summary: A 23-year-old highly myopic female who presented with PIC in her right eye was treated with an intravitreal dexamethasone implant due to side effects of systemic steroid treatment including facial edema and sleep disturbances. Three months after the implant she complained of severe acute visual disturbances in her right eye. Her visual acuity was classified as hand movement. Choroidal neovascularization (CNV) was observed on optical coherence tomography and indocyanine green angiography revealed more multiple hypofluorescent lesions compared to the initial visit. Six months after the systemic steroid and intravitreal bevacizumab injection treatments, visual acuity in right eye improved and the CNV disappeared. Conclusions: This report describes a case of PIC after, treatment with an intravitreal dexamethasone implant due to the side effects of systemic steroid treatment, which recurred with complications.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.